Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion

The frequency of IOP events noted in SCORE2 support monitoring IOP in eyes treated with anti-VEGF therapy for macular edema secondary to central retinal vein occlusion or hemiretinal vein occlusion https://t.co/3dmmp3Z8Zw

Congrats to Jacquie King, Neal Oden & Paul Van Veldhuisen on publication of "Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusio…

Report 16 of Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) show 8.0% had IOP elevations >10mmHg & 1.6% had IOP >35mmHg at 60mths, highlighting the importance of regularly IOPs checks in px undergoing anti-VEGF tx. https…

The frequency of IOP events noted in SCORE2 support monitoring IOP in eyes treated with anti-VEGF therapy for macular edema secondary to central retinal vein occlusion or hemiretinal vein occlusion https://t.co/kiPrfECvEn